Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice

被引:78
作者
Berul, CI
Christe, ME
Aronovitz, MJ
Seidman, CE
Seidman, JG
Mendelsohn, ME
机构
[1] TUFTS UNIV,DIV PEDIAT CARDIOL,SCH MED,NEW ENGLAND MED CTR,BOSTON,MA 02111
[2] TUFTS UNIV,DIV CARDIOL,SCH MED,NEW ENGLAND MED CTR,BOSTON,MA 02111
[3] HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02111
关键词
cardiomyopathy; hypertrophy; electrophysiology; disease models; animals; drug screening; hereditary diseases;
D O I
10.1172/JCI119197
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A new mouse cardiac electrophysiology method was used to study mice harboring an alpha-myosin heavy chain Arg403Gln missense mutation (alpha-MHC(403/+)), which results in histological and hemodynamic abnormalities characteristic of familial hypertrophic cardiomyopathy (FHC) and sudden death of uncertain etiology during exercise. Wild-type animals had completely normal cardiac electrophysiology. In contrast, FHC mice demonstrated (a) electrocardiographic abnormalities including prolonged repolarization intervals and rightward axis; (b) electrophysiological abnormalities including heterogeneous ventricular conduction properties and prolonged sinus node recovery time; and (c) inducible ventricular ectopy. These data identify distinct electrophysiologic abnormalities in FHC mice with a specific alpha-myosin mutation, and also validate a novel method to explore in vivo the relationship between specific genotypes and their electrophysiologic phenotypes.
引用
收藏
页码:570 / 576
页数:7
相关论文
共 31 条
  • [1] Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
  • [2] USE OF THE RATE-CORRECTED JT INTERVAL FOR PREDICTION OF REPOLARIZATION ABNORMALITIES IN CHILDREN
    BERUL, CI
    SWEETEN, TL
    DUBIN, AM
    SHAH, MJ
    VETTER, VL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (12) : 1254 - 1257
  • [3] In vivo cardiac electrophysiology studies in the mouse
    Berul, CI
    Aronovitz, MJ
    Wang, PJ
    Mendelsohn, ME
    [J]. CIRCULATION, 1996, 94 (10) : 2641 - 2648
  • [4] COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN-DEATH
    BUJA, G
    MIORELLI, M
    TURRINI, P
    MELACINI, P
    NAVA, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (12) : 973 - 976
  • [5] NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY - A POPULATION-BASED STUDY, 1976 THROUGH 1990
    CANNAN, CR
    REEDER, GS
    BAILEY, KR
    MELTON, LJ
    GERSH, BJ
    [J]. CIRCULATION, 1995, 92 (09) : 2488 - 2495
  • [6] DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION
    EPSTEIN, ND
    COHN, GM
    CYRAN, F
    FANANAPAZIR, L
    [J]. CIRCULATION, 1992, 86 (02) : 345 - 352
  • [7] HEMODYNAMIC AND ELECTROPHYSIOLOGIC EVALUATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY SURVIVING CARDIAC-ARREST
    FANANAPAZIR, L
    EPSTEIN, SE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (04) : 280 - 287
  • [8] PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS
    FANANAPAZIR, L
    CHANG, AC
    EPSTEIN, SE
    MCAREAVEY, D
    [J]. CIRCULATION, 1992, 86 (03) : 730 - 740
  • [9] A mouse model of familial hypertrophic cardiomyopathy
    GeisterferLowrance, AAT
    Christe, M
    Conner, DA
    Ingwall, JS
    Schoen, FJ
    Seidman, CE
    Seidman, JG
    [J]. SCIENCE, 1996, 272 (5262) : 731 - 734
  • [10] Gillette PC, 1990, PEDIAT ARRHYTHMIAS E, P216